About Epignostix
Cancer classification you can act on We combine leading scientific and medical expertise with innovative technology to improve diagnostic accuracy and enhance clinical care for cancer patients. Learn more What we enable Enabling cancer diagnostics and precision oncology
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Seed
Global Headquarters
Undisclosed
Tracked Since
Nov 8, 2026
Web & Domain Identity
Official Website
epignostix.com
Domain Registered Date
Undisclosed
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised undisclosed · Seed
fundraisingfox.com
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for Epignostix.
Funding History
Seed equity
· Jul 2, 2024
undisclosed fundraisingfox.com
Founders & Leadership
Daniel Schrimpf
Head of Software Development & Co-founder
Work email & phone locked
Unlock →
David Jones
Chief Scientific Officer & Co-founder
Work email & phone locked
Unlock →
Felix Sahm
Chief Medical Advisor & Co-founder
Work email & phone locked
Unlock →
Martin Sill
Head of Data Science & Co-founder
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Seed Nov 2026
Commit Biologics
commitbio.com
Seed Aarhus · Nov 2026
Human Biome
human-biome.com
Series-A Warsaw · Nov 2026
MedInTech
medintech.co.kr
Series-B Seoul · Nov 2026
Ace Padel
acepadel.com
Seed Bradenton, United States · Nov 2026
Mentix
mentix.world
Pre-Seed London, United Kingdom · Nov 2026